We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox Launches New Innovations

By LabMedica International staff writers
Posted on 06 Aug 2019
Global diagnostics firm Randox Laboratories (Crumlin, UK) showcased its unique life science capabilities in areas, including stroke differentiation and quality control for a range of infectious diseases, at the world’s largest laboratory medicine conference – the AACC Annual Scientific Meeting & Clinical Lab Expo – in California, USA. More...
The 71st event from the American Association for Clinical Chemistry (AACC) highlighted the best in the industry on the world stage once again, as clinicians, companies and customers from all over the world flocked to the Californian Anaheim Convention Center from August 4-8, 2019.

At this year’s AACC event, Randox launched a number of exciting new innovations, including a new offering of Infectious Disease Serology Internal Quality Controls which includes quality control material vital for the testing of Lyme Disease, ToRCH, EBV, HIV, HAV, HTLV, CMV, VZV and much more. All samples are provided in a user-friendly, liquid ready-to-use format, which significantly reduces preparation time and the risk of pipetting errors. Randox also launched its whole pathogen Blood Borne Virus Controls sold under the brand name Qnostics that are versatile in monitoring the presence of BBVs, including HIV, Hepatitis B and Hepatitis C.

For use with molecular methods, the controls are manufactured using whole pathogens and therefore, mimic the patient sample, providing the best sample matrix for laboratories. Among its QC solutions, Randox highlighted its Acusera Linearity Sets that are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. The company’s linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all the linearity sets are supplied in a liquid format, while also presented in varying levels.

At AACC, Randox unveiled its brand new Randox Stroke Biochip, an advancement of its Biochip Array Technology, which is a multi-analyte testing platform facilitating the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. The Randox Stroke Biochip is a rapid and highly sensitive blood test that will complement and enhance existing CT scanning technology to facilitate accurate classification of stroke patients and improve patient care pathways. It provides a unique solution for simultaneous detection of multiple stroke biomarkers from a single sample, facilitating fast and accurate classification of stroke patients in an emergency setting.

Randox also announced 510 (K) clearance from the US Food and Drug Administration for its RX daytona+ fully automated, benchtop, clinical chemistry analyzer that is capable of performing high quality testing, including emergency STAT sampling, and boasts of a combined throughput of 450 tests per hour including ISE. At AACC 2019, Randox highlighted its fully automated Evidence+ batch immunoanalyzer that simultaneously detects multiple drugs and drug metabolites from a single sample and also announced its new automated assay for sPLA2-IIA mass.

“We look forward to AACC every year as we exhibit our constantly-evolving revolutionary technologies,” said Randox Managing Director, Dr. Peter FitzGerald. “This year, we will once again highlight Randox’s ground-breaking diagnostic products and services which help to save and extend lives across the world.”


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.